The Oncology Institute Execs to Present at B. Riley Conference
Event summary
- The Oncology Institute (NASDAQ: TOI) will participate in B. Riley Securities Institutional Investor Conference on May 21, 2026.
- CEO Dr. Daniel Virnich and CFO Rob Carter will lead a fireside chat from 9:00–9:40 a.m. PT.
- The event will be webcast via the company’s Investor Relations page.
- TOI operates over 100 clinics across five states, serving 1.9 million patients.
The big picture
The Oncology Institute’s participation in the B. Riley conference underscores its push to strengthen investor relations amid a shifting landscape in oncology care delivery. As value-based models gain traction, TOI’s ability to scale its clinic network while maintaining high-quality care will be critical. The event provides a platform for the company to address its strategic direction and financial health in a competitive market.
What we're watching
- Strategic Messaging
- How TOI positions its value-based oncology model amid rising competition in community cancer care.
- Financial Performance
- Whether TOI can sustain growth with its expanding clinic network and patient base.
- Investor Sentiment
- The impact of the conference presentation on TOI’s stock valuation and investor confidence.
Related topics